sodium fusidate (CEM-102)

sodium fusidate · Arrevus Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for sodium fusidate (CEM-102), covering 2020-01-30 to 2020-01-30. Get the full timeline:

Most recent: Clinical Trial Update: Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint Infections [Phase 2, Phase 3]